Met PG 2mg/500mg/15mg Tablet SR
Marketer
Elis Pharmaceuticals India Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Met PG 2mg/500mg/15mg Tablet SR
The extended-release tablet, Met PG 2mg/500mg/15mg, is a combined medication for managing blood glucose. In adults with type 2 diabetes, it complements diet and exercise to enhance glycemic control by improving insulin effectiveness and reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take it with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be skipped. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates the hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be assessed by your doctor before prescribing. Limit alcohol consumption to minimize potential adverse reactions.
Uses of Met PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Met PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met PG 2mg/500mg/15mg sustained-release tablet should be administered with a meal.
Common Side effects of Met PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Met PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met PG 2mg/500mg/15mg Extended-Release tablet should be taken with meals.
How Met PG 2mg/500mg/15mg Tablet SR works:
Met PG 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual-agent regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Met PG 2mg/500mg/15mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Met PG 2mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet, Met PG 2mg/500mg/15mg, is likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Met PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Met PG 2mg/500mg/15mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Met PG 2mg/500mg/15mg SR tablets cautiously, as dosage modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. Medical advice is recommended.
What if you forget to take Met PG 2mg/500mg/15mg Tablet SR :
Should you forget a Met PG 2mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Met PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently